Twist Bioscience Corp (TWST) — Financial Flexibility Index
Twist Bioscience Corp (TWST) has a Financial Flexibility Index of -0.04x as of March 2026. Free cash flow of $-9.57 Million (operating CF $-17.56 Million minus capex $7.99 Million) represents 0% of total liabilities ($221.12 Million). Check strategic asset allocation of Twist Bioscience Corp to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Twist Bioscience Corp Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Twist Bioscience Corp across 10 annual periods. See Twist Bioscience Corp working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Twist Bioscience Corp (2016–2025)
Year-by-year free cash flow to debt coverage for Twist Bioscience Corp. For the full company profile including market capitalisation, see Twist Bioscience Corp market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-19.62 Million | $-47.63 Million | $168.90 Million | ▲ +72.1% |
| 2024 | -0.42x | $-59.02 Million | $-64.09 Million | $141.63 Million | ▲ +44.4% |
| 2023 | -0.75x | $-114.69 Million | $-142.47 Million | $152.97 Million | ▼ -472.4% |
| 2022 | -0.13x | $-22.53 Million | $-124.39 Million | $171.99 Million | ▲ +81.4% |
| 2021 | -0.70x | $-85.18 Million | $-112.24 Million | $121.28 Million | ▲ +66.8% |
| 2020 | -2.11x | $-132.39 Million | $-142.25 Million | $62.62 Million | ▼ -0.9% |
| 2019 | -2.10x | $-73.18 Million | $-87.94 Million | $34.91 Million | ▼ -964.3% |
| 2018 | -0.20x | $-62.48 Million | $-66.16 Million | $317.21 Million | ▲ +3.5% |
| 2017 | -0.20x | $-44.71 Million | $-51.30 Million | $219.01 Million | ▲ +3.4% |
| 2016 | -0.21x | $-32.36 Million | $-38.59 Million | $153.07 Million | — |